Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02607228
Brief Title: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 (Alobresib) as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer

First Submitted : November 16, 2015
First Submitted that Met QC Criteria : November 16, 2015
First Posted : November 17, 2015 (Estimate)

Results First Submitted : September 3, 2020
Results First Submitted that Met QC Criteria : December 4, 2020
Results First Posted : December 8, 2020

Certification/Extension First Submitted : October 19, 2018
Certification/Extension First Submitted that Met QC Criteria : October 19, 2018
Certification/Extension First Posted : October 23, 2018

Last Update Submitted that Met QC Criteria : December 4, 2020
Last Update Posted : December 8, 2020